Profil
Justin Xiang is the founder and Chief Investment Officer at Syno Partners LLC, which he founded in 2015.
He is currently a Director at Seaport Diagnostics, Inc. Dr. Xiang was also a Director at LungLife AI, Inc.
Aktive Positionen von Justin Xiang
Unternehmen | Position | Beginn |
---|---|---|
Seaport Diagnostics, Inc.
Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | - |
Syno Partners LLC
Syno Partners LLC Investment ManagersFinance Syno Partners LLC (Syno Partners) is a venture capital firm founded in 2015 by Justin Xiang and Joseph Weilgus. The firm is headquartered in New York. | Gründer | 01.01.2015 |
Ehemalige bekannte Positionen von Justin Xiang
Unternehmen | Position | Ende |
---|---|---|
LUNGLIFE AI, INC. | Direktor/Vorstandsmitglied | 01.07.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
LUNGLIFE AI, INC. | Health Services |
Private Unternehmen | 2 |
---|---|
Seaport Diagnostics, Inc.
Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA. | Health Technology |
Syno Partners LLC
Syno Partners LLC Investment ManagersFinance Syno Partners LLC (Syno Partners) is a venture capital firm founded in 2015 by Justin Xiang and Joseph Weilgus. The firm is headquartered in New York. | Finance |